| Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 82.05K | $ 200.75K | $ 277.09K | $ 3.07M | $ 6.70M |
| Gross Profit | $ 58.28K | $ 148.72K | $ 212.97K | $ 1.74M | $ 4.59M |
| Operating Income | $ -1.72M | $ -2.14M | $ -2.40M | $ -3.42M | $ -1.10M |
| EBITDA | $ -2.17M | $ -151.41K | $ -2.40M | $ -2.61M | $ -508.49K |
| Net Income | $ -2.86M | $ -3.29M | $ -2.89M | $ -3.84M | $ -2.16M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 5.13K | $ 39.39K | $ 18.57K | $ -10.00K | $ 1.36M |
| Total Assets | $ 68.04K | $ 51.00K | $ 88.15K | $ 89.84K | $ 1.82M |
| Total Debt | $ 8.95M | $ 8.02M | $ 7.48M | $ 6.18M | $ 5.05M |
| Net Debt | $ 8.94M | $ 7.98M | $ 7.47M | $ 6.18M | $ 3.69M |
| Total Liabilities | $ 14.81M | $ 12.82M | $ 11.67M | $ 9.57M | $ 8.70M |
| Stockholders' Equity | $ -14.75M | $ -12.77M | $ -11.58M | $ -9.48M | $ -6.88M |
| Cash Flow | |||||
| Free Cash Flow | $ -304.85K | $ -1.06M | $ -478.89K | $ -1.21M | $ 602.47K |
| Operating Cash Flow | $ -304.85K | $ -1.06M | $ -478.89K | $ -1.21M | $ 602.47K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 166.83K | $ 311.70K |
| Financing Cash Flow | $ 270.59K | $ 1.08M | $ 497.46K | $ -312.99K | $ -543.82K |
US Stem Cell Inc (USRM)
OTHER OTC:USRM
